Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology ...Middle East

The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields. Both formulations tested induced strong systemic antibody response in serum (IgG) as well as locally in the...

Hence then, the article about orexo announces positive data for powder based intranasal vaccine formulated with the amorphox technology was published today ( Thursday 10/04/2025 - 09:27 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology )

Also on site :

• Texas Launches $350 Million Nuclear Energy Initiative
• Tottenham Hotspur book and used pyjamas among ‘most disappointing’ Christmas gifts, survey reveals
• National Oil Companies Quietly Set The Pace For The Next Decade